Association between dietary inflammation index and hypertension in participants with different degrees of liver steatosis

References

• Younossi ZM, Blissett D, Blissett R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1–11.
   PubMed Web of Science ®Google Scholar
• European association for the study of the L, european association for the study of D, European association for the study of O. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–1402.
   PubMed Web of Science ®Google Scholar
• Italian association for the study of the L. AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions. Dig Liver Dis. 2017;49(5):471–483.
   PubMedGoogle Scholar
• Ciardullo S, Perseghin G. Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver Int. 2021;41(6):1290–1293.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71(6):e13–e115.
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380(9841):601–610.
   PubMed Web of Science ®Google Scholar
• Qian L-Y, Tu J-F, Ding Y-H, et al. Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: normal is not the new normal. Medicine . 2016;95(29):e4293.
   PubMed Web of Science ®Google Scholar
• Lorbeer R, Bayerl C, Auweter S, et al. Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease. J Hypertens. 2017;35(4):737–744.
   PubMed Web of Science ®Google Scholar
• Lopez-Suarez A, Guerrero JM, Elvira-Gonzalez J, et al. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. Eur J Gastroenterol Hepatol. 2011;23(11):1011–1017.
   PubMed Web of Science ®Google Scholar
• Ciardullo S, Monti T, Grassi G, et al. Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population. J Hypertens. 2021;39(8):1621–1627.
   PubMed Web of Science ®Google Scholar
• Ciardullo S, Monti T, Sala I, et al. Nonalcoholic fatty liver disease and advanced fibrosis in US adults across blood pressure categories. Hypertension. 2020;76(2):562–568.
   PubMed Web of Science ®Google Scholar
• Ma J, Hwang SJ, Pedley A, et al. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. J Hepatol. 2017;66(2):390–397.
   PubMed Web of Science ®Google Scholar
• Lonardo A, Nascimbeni F, Mantovani A, et al. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol. 2018;68(2):335–352.
   PubMed Web of Science ®Google Scholar
• Oikonomou D, Georgiopoulos G, Katsi V, et al. Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated? Eur J Gastroenterol Hepatol. 2018;30(9):979–985.
   PubMed Web of Science ®Google Scholar
• Haukeland JW, Damas JK, Konopski Z, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44(6):1167–1174.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee CH, Kim S, et al. Association between vascular inflammation and non-alcoholic fatty liver disease: analysis by (18)F-fluorodeoxyglucose positron emission tomography. Metabolism. 2017;67:72–79.
   PubMed Web of Science ®Google Scholar
• Sinn DH, Kang D, Jang HR, et al. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: a cohort study. J Hepatol. 2017;67(6):1274–1280.
   PubMed Web of Science ®Google Scholar
• Adolph TE, Grander C, Grabherr F, et al. Adipokines and non-alcoholic fatty liver disease: multiple interactions. IJMS. 2017;18(8):1649.
   Google Scholar
• Faulkner JL, Belin de Chantemele EJ. Sex differences in mechanisms of hypertension associated with obesity. Hypertension. 2018;71(1):15–21.
   PubMed Web of Science ®Google Scholar
• Shivappa N, Steck SE, Hurley TG, et al. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689–1696.
   PubMed Web of Science ®Google Scholar
• Julia C, Assmann KE, Shivappa N, et al. Long-term associations between inflammatory dietary scores in relation to long-term C-reactive protein status measured 12 years later: findings from the supplementation en vitamines et mineraux antioxydants (SU.VI.MAX) cohort. Br J Nutr. 2017;117(2):306–314.
   PubMed Web of Science ®Google Scholar
• Tabung FK, Steck SE, Zhang J, et al. Construct validation of the dietary inflammatory index among postmenopausal women. Ann Epidemiol. 2015;25(6):398–405.
   PubMed Web of Science ®Google Scholar
• Wirth MD, Sevoyan M, Hofseth L, et al. The dietary inflammatory index is associated with elevated white blood cell counts in the national health and nutrition examination survey. Brain Behav Immun. 2018;69:296–303.
   PubMed Web of Science ®Google Scholar
• Shivappa N, Godos J, Hebert JR, et al. Dietary inflammatory index and colorectal cancer risk-a meta-analysis. Nutrients. 2017;9(9):1043.
   PubMed Web of Science ®Google Scholar
• Zahedi H, Djalalinia S, Asayesh H, et al. A higher dietary inflammatory index score is associated with a higher risk of incidence and mortality of cancer: a comprehensive systematic review and Meta-Analysis. Int J Prev Med. 2020;11:15.
   PubMed Web of Science ®Google Scholar
• Ruiz-Canela M, Zazpe I, Shivappa N, et al. Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvencion con DIeta MEDiterranea) trial. Br J Nutr. 2015;113(6):984–995.
   PubMed Web of Science ®Google Scholar
• Qin Z, Yang Q, Liao R, et al. The association between dietary inflammatory index and parathyroid hormone in adults with/without chronic kidney disease. Front Nutr. 2021;8:688369.
   PubMed Web of Science ®Google Scholar
• Geng J, Deng L, Qiu S, et al. Dietary inflammatory potential and risk of sarcopenia: data from national health and nutrition examination surveys. Aging . 2020;13(2):1913–1928.
   PubMedGoogle Scholar
• Centers for disease control and prevention National health and nutrition examination survey (NHANES). U.S. Department of Health and Human Services. 2017. https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default. aspx?BeginYear=2017
   Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Hepatology. 2012;55(6):2005–2023.
   PubMed Web of Science ®Google Scholar
• Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264–1281.e4. e4
   PubMed Web of Science ®Google Scholar
• Eddowes PJ, Sasso M, Allison M, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717–1730.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):2199–2269.
   PubMed Web of Science ®Google Scholar
• Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9 Suppl):S498–S504.
   PubMed Web of Science ®Google Scholar
• Kidney disease: improving global outcomes glomerular diseases work G. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4S):S1–S276.
   PubMedGoogle Scholar
• National Center for Health Statistics. National health and nutrition examination survey 2017–2018 laboratory data. [Internet] https://wwwn.cdc.gov/nchs/nhanes/ Search/DataPage.aspx?Component=Laboratory&CycleBegin. [Accessed June 2020].
   Google Scholar
• Tsuneto A, Hida A, Sera N, et al. Fatty liver incidence and predictive variables. Hypertens Res. 2010;33(6):638–643.
   PubMed Web of Science ®Google Scholar
• Sorrentino P, Terracciano L, D’Angelo S, et al. Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension. Am J Gastroenterol. 2010;105(2):336–344.
   PubMed Web of Science ®Google Scholar
• Vasunta RL, Kesaniemi YA, Ylitalo AS, et al. High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults. J Hypertens. 2012;30(10):2015–2019.
   PubMed Web of Science ®Google Scholar
• Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308(9):875–881.
   PubMed Web of Science ®Google Scholar
• Bai L, Li H. Innate immune regulatory networks in hepatic lipid metabolism. J Mol Med. 2019;97(5):593–604.
   PubMed Web of Science ®Google Scholar
• Nunes KP, de Oliveira AA, Mowry FE, et al. Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension? Br J Pharmacol. 2019;176(12):1864–1879.
   PubMed Web of Science ®Google Scholar
• Carnagarin R, Matthews V, Zaldivia MTK, et al. The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension. Br J Pharmacol. 2019;176(12):1839–1852.
   PubMed Web of Science ®Google Scholar
• Satou R, Penrose H, Navar LG. Inflammation as a regulator of the Renin-Angiotensin system and blood pressure. Curr Hypertens Rep. 2018;20(12):100.
   PubMed Web of Science ®Google Scholar
• Alkerwi A, Shivappa N, Crichton G, et al. No significant independent relationships with cardiometabolic biomarkers were detected in the observation of cardiovascular risk factors in Luxembourg study population. Nutr Res. 2014;34(12):1058–1065.
   PubMed Web of Science ®Google Scholar
• Zhang X, Guo Y, Yao N, et al. Association between dietary inflammatory index and metabolic syndrome: analysis of the NHANES 2005–2016. Front Nutr. 2022;9:991907.
   PubMedGoogle Scholar
• Kander MC, Cui Y, Liu Z. Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med. 2017;21(5):1024–1032.
   PubMed Web of Science ®Google Scholar
• Knowlton AA, Lee AR. Estrogen and the cardiovascular system. Pharmacol Ther. 2012;135(1):54–70.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–1252.
   PubMed Web of Science ®Google Scholar
• Nolde JM, Beaney T, Carnagarin R, et al. Global impact of different blood pressure thresholds in 4 021 690 participants of the may measurement month initiative. Hypertension. 2022;79(7):1497–1505.
   PubMed Web of Science ®Google Scholar